Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1988-09-09
1990-10-16
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514885, 514934, A61K 3170
Patent
active
049635328
ABSTRACT:
dsRNA reduces the phenomenon of viral escape and cellular damage attendant thereto. Viral escape is a process by which a virus of intracellular pathogen alters its host range or indirectly alters its susceptibility to antiviral or immunological therapies. Viruses do so by causing specific changes in their genomic/antigenic composition and/or by causing the elaboration of factors which enhance destructiveness of cells and their ability to multiply progeny virus. Animals susceptible to viral infections and pathology secondary to antigenic drift may have damage reduced by exposing them to dsRNA which prevents or substantially minimizes viral escape brought about through these mechanisms of molecular rearrangement and/or elaboration of factors which break down the natural host defenses.
REFERENCES:
patent: 4795744 (1989-01-01), Carter
HEM Research, Inc.
Rollins John W.
LandOfFree
dsRNA-based prevention of viral escape does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with dsRNA-based prevention of viral escape, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and dsRNA-based prevention of viral escape will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-849921